StreetAlpha.app
Home › Stocks › TELA

TELA Bio, Inc. (TELA)

$0.76
▲ +0.07%
LAST CLOSE · NOV 17

TELA Bio makes soft tissue repair matrices used by surgeons for hernia repair and plastic and reconstructive surgery. It last closed at $0.76 on Nov 17, up 0.07% on the day.

AI Auto Pilots
Is TELA in one of our four AI portfolios? Sign in free to see

Key Stats

Last 12 months
Results
Revenue
$78.2M
+1.5% vs a year ago
Net income
−$41.9M
−53.6% margin
EPS (diluted)
−$0.74
Free cash flow
−$34.4M
−44.0% margin
Valuation
Market cap
$34.4M
45.2M shares
P/E
–
No P/E while losing money
Price to sales
0.4
Market cap over revenue
Dividend yield
None
No dividend in 12 months
Balance sheet
Cash & equivalents
$22.7M
At Sep 30
Debt
$56.1M
At Jun 30
Shareholder equity
−$24.6M
Shares outstanding
45.2M
At Nov 5
Fiscal year endsDecember
ExchangeNasdaq
Financials history
FY2021: $29.5M$29.5MFY2021FY2022: $41.4M$41.4MFY2022FY2023: $58.5M$58.5MFY2023FY2024: $69.3M$69.3MFY2024FY2025: $80.3M$80.3MFY2025

From TELA's SEC filings, latest 10-Q for the period ending Sep 30, 2026 (filed Nov 10). Last 12 months adds up the four latest quarters.

Last report
Nov 10
2026 · next date not on the calendar yet
Consensus EPS forecast
—
 
Year-ago EPS
—
Not on file
Options-implied move
—
 
Analyst consensus
1 Buy
1 firm · not enough for a consensus
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Ratings · 90 days
1 Buy
1firm
1 Buy0 Hold0 Sell
Only 1 firm rated TELA in the past 90 days, not enough for a consensus
Average 12-month target
$2.00
▲ 162.4% upside

Based on 1 analyst who set a price target on TELA in the past 90 days. The average target is $2.00, with a high of $2.00 and a low of $2.00, compared with the last close of $0.76.

Low $2.00Avg $2.00High $2.00
Blue marker: last close $0.76
Highest target$2.00
Average target$2.00
Lowest target$2.00
Latest rating changes
Craig-HallumInitiated
Sep 25Buy$2
DateFirmActionRatingPrice target
Sep 25Craig-HallumInitiatedBuy$2
Loading…

Technical Analysis

TELA · as of the Nov 17 close · updated after every close
Turning down

The stock is 15% below its 20 day and 35% below its 50 day average. It is 11% below its 200 day average, so the longer trend is down. Momentum is weak (RSI 39). The nearest support is the Pivot S1 at $0.75, and the nearest resistance the Pivot at $0.77.

Short trendBearish
Long trendNeutral
MomentumWeak
StretchNormal
VolatilityHigh, 15.0%/day
Key levels
$1.5052 week high+97.4%
$1.0350 day average+35.5%
$0.89100 day average+17.1%
$0.8820 day average+15.8%
$0.85200 day average+11.8%
$0.80Swing high (Jul 23)+5.3%
$0.78Pivot R1+2.6%
$0.77Pivot+1.3%
$0.76Last close
$0.75Pivot S1−1.3%
$0.70Swing low (Jul 20)−7.9%
$0.5052 week low−34.2%
Indicators
RSI (14)39.39Weak, oversold below 30Neutral
MACD-0.06Below its signal lineBearish
Stochastic30.8Middle of its rangeNeutral
ADX (14)16.6No clear trend
Williams %R-72.4Oversold below −80, overbought above −20Neutral
CCI (20)-99.8Oversold below −100, overbought above 100Neutral
Rate of change−3.6%Change over 10 sessionsBearish
ATR (14)$0.11Typical daily range, 15.0% of price
MA 10Below
MA 20Below
MA 50Below
MA 100Below
MA 200Below
What happened before, for TELA

What happened before

See how TELA did after each of today's signals in the past: how often it was higher 10 sessions later, and the typical move, next to its usual record.

November seasonalityHow TELA usually does this month. See Seasonality

Calculated from daily prices after each close. Signals describe the chart, not where the stock will go. Past patterns often fail. Not investment advice.

Seasonality

How TELA has done in each calendar month: the average and median return, how often each month finished higher, and every year since 2019.

Loading…

See the stocks that usually rise in November →

Whale Options Flow

90D

No whale options trades in TELA in the last 90 days.

Loading…

See today’s whale options flow across the market →

TELA Institutional Ownership

Full report →
Fund sentiment · Q3 2026
Neutral
Strongly bearishNeutralStrongly bullish
  • ▲21 buying vs 13 selling
  • ▼Held by funds -11.9 pts
  • ▲Funds holding +3
  • ●Superinvestors: 1 added, 1 cut
  • ●Put/call not meaningful
Q4 '24Q1 '25Q2 '25Q3 '25Q4 '25Q1 '26Q2 '26Q3 '26
Funds holdingHeld by funds %
Q3 2026This quarterLast quarterChange
Funds holding4845+6.7%
In funds' top 10110.0%
Held by funds58.1%70.0%−11.9 pts
New / increased8 / 1310 / 12−4.5%
Reduced / sold out7 / 610 / 1+18.2%
Put/call ratio–––
Top holders, biggest buyers and sellers, 8 quarters of charts and this season's filings so far.See TELA institutional ownership →

From SEC Form 13F filings for Sep 30, 2026. What the filings show, not a forecast: positions can be up to 45 days old and leave out short sales.

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether TELA is in one of them and how their past TELA trades turned out.

TELA in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered TELA in an article yet. Here's the latest on the wider market.

About TELA Bio

TELA Bio is a medical technology company based in Malvern, Pennsylvania. It sells soft tissue reconstruction products, mainly tissue matrices that surgeons use to repair hernias and to reinforce tissue in plastic and reconstructive surgery. The matrices are made from sheep tissue combined with polymer materials and are sold mainly to surgeons and hospitals in the United States and Europe. The company also distributes some complementary surgical products made by other manufacturers.

Headquarters
Malvern, PA